Peptide Therapy Cost Guide (2026)

Peptide therapy pricing varies more than most users expect because clinics bundle very different things into the headline number. Some providers quote a simple medication-only monthly fee, while others include clinician review, follow-up appointments, messaging access, diagnostics, and a broader treatment plan. That means two clinics can both advertise peptide therapy while delivering very different levels of medical oversight.

For GLP-1 programmes such as semaglutide and tirzepatide, many clinics fall somewhere between $200 and $900 per month depending on medication source, dose escalation support, and how much clinician follow-up is included. Lower-friction telehealth models often sit at the lower end, while concierge or physician-led programmes with stronger monitoring can sit materially higher.

BPC-157 discussions are often packaged into recovery-oriented or regenerative medicine pathways. In practical directory terms, users may see pricing in the rough range of $150 to $450 per month, but the number only becomes meaningful when you know whether the clinic includes medical review, baseline screening, and follow-up care.

TB-500 is frequently framed similarly to BPC-157 within recovery and performance-oriented clinic contexts. Monthly pricing commonly sits in a similar broad band, often around $150 to $450 per month, though actual clinic models vary and some providers discuss TB-500 only as part of a combined protocol rather than a standalone line item.

TRT-related peptides and adjacent hormone support programmes can range from roughly $100 to $350 per month for simpler maintenance models, while more comprehensive optimisation programmes cost more when they include blood work, physician reviews, and a larger care plan.

What affects cost most is not just the compound name. The biggest pricing drivers are clinician time, labs, medication sourcing, the frequency of follow-up, whether the clinic is concierge or transactional, and whether multiple services are bundled together.

Are cheaper clinics safe? Not necessarily unsafe, but lower pricing should trigger more scrutiny. Ask who is prescribing, what assessment is performed before treatment is discussed, how side effects are monitored, and what happens if a protocol needs to change. Cost matters, but governance matters more.

If you are comparing providers, start with city-level pages such as Miami and Los Angeles, then cross-reference peptide-specific pages like BPC-157 to understand how clinics position treatments before you contact them. This guide is informational only and does not recommend any clinic or therapy.